Next |
home / stock / rdhl / rdhl message board
Subject | By | Source | When |
---|---|---|---|
RedHill's RHB-102 (BEKINDA) and Opaganib Granted New Patents | midastouch017 | investorshub | 05/01/2023 12:05:58 PM |
JOHANNESBURG, April 28, 2023 /PRNewswire/ --(NASDAQ: $RDHL) (RedHill | midastouch017 | investorshub | 04/28/2023 4:37:20 PM |
Whatever happened to the crohns disease drug? They | seve333 | investorshub | 04/28/2023 3:18:25 PM |
Discussions for potential commercialization partners are ongoing. | midastouch017 | investorshub | 04/28/2023 12:33:27 PM |
RedHill Biopharma Announces Q4/22 & Full-Year 2022 Results | midastouch017 | investorshub | 04/28/2023 12:26:42 PM |
bears are running | seve333 | investorshub | 04/27/2023 10:56:09 PM |
$RDHL is it bear time? Or do we go bull? | midastouch017 | investorshub | 04/27/2023 9:37:59 PM |
$RDHL MomentumIts gaining up | midastouch017 | investorshub | 04/27/2023 5:52:08 PM |
$RDHL MomentumIts gaining | mick | investorshub | 04/27/2023 5:00:19 PM |
$RDHL good read | Big Wheel | investorshub | 04/27/2023 4:16:23 PM |
$RDHL Price gaining | midastouch017 | investorshub | 04/27/2023 3:01:36 PM |
Found an interesting article | midastouch017 | investorshub | 04/27/2023 2:53:31 PM |
$RDHL Price now last trade up | mick | investorshub | 04/27/2023 10:21:17 AM |
$RDHL we got news | midastouch017 | investorshub | 04/27/2023 8:46:25 AM |
Time for this to show some returns | midastouch017 | investorshub | 04/27/2023 7:07:02 AM |
Long and strong lets hope im right | midastouch017 | investorshub | 04/27/2023 4:00:05 AM |
$RDHL are we finally gonna see some action | midastouch017 | investorshub | 04/27/2023 3:26:24 AM |
Price gaining | carusso | investorshub | 04/27/2023 2:35:41 AM |
$RDHL MomentumIts now up | carusso | investorshub | 04/27/2023 12:10:15 AM |
$RDHL Do we have a winner?Turn around time? | Big Wheel | investorshub | 04/26/2023 11:35:14 PM |
News, Short Squeeze, Breakout and More Instantly...
Redhill Biopharma Ltd. Company Name:
RDHL Stock Symbol:
NASDAQ Market:
RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035 PR Newswire The new Chinese patent for opaganib as a therapy for inhibition of single-stranded RNA virus replication (notably Ebola Disease Virus) is valid through 2035 and adds to opaganib's ...
RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study PR Newswire First patient enrolled in the global, 300-patient, Phase 2 adaptive platform trial arm of RHB-107 (upamostat) 1 for early COVID-19 outpatient treatment, funded through non-...
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights PR Newswire RedHill continues corporate transformation to focus on U.S. government-funded pipeline development in underserved, sizeable therapeutic areas with a disciplined cost-base ...